{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02095",
      "entity_text" : "AT2 receptors",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00618",
      "entity_text" : "Angiotensin-receptor",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Angiotensin-receptor blockers (ARBs) selectively antagonize angiotensin II at the AT1 receptors and increase the activation of the AT2 receptors.",
  "reading_complete" : "2020-07-28T14:56:08Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T14:55:34Z",
  "trigger" : "increase",
  "evidence" : [ "Angiotensin-receptor blockers (ARBs) selectively antagonize angiotensin II at the AT1 receptors and increase the activation of the AT2 receptors" ],
  "pmc_id" : "2811448",
  "score" : 0
}